Product Code: ETC13249858 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Drug-eluting Stents Market was valued at USD 6.9 Billion in 2024 and is expected to reach USD 13.6 Billion by 2031, growing at a compound annual growth rate of 10.59% during the forecast period (2025-2031).
The Global Drug-eluting Stents Market is a rapidly growing sector within the medical devices industry, driven by the increasing prevalence of cardiovascular diseases worldwide. These stents are used in the treatment of coronary artery disease, providing a solution for patients who require artery-opening procedures such as angioplasty. The market is characterized by technological advancements in stent design, drug coatings, and the materials used, leading to improved efficacy and reduced risks of complications. Key players in the market are investing heavily in research and development to introduce innovative products and expand their market presence. North America and Europe dominate the market due to high healthcare expenditure, while the Asia-Pacific region is witnessing significant growth due to rising healthcare infrastructure and increasing adoption of advanced medical technologies.
The Global Drug-eluting Stents Market is experiencing a trend towards the development of next-generation stents with advanced drug coatings and improved design features to enhance efficacy and safety. There is also a growing focus on personalized medicine, with the use of innovative technologies such as bioresorbable stents and drug-eluting balloons. Additionally, the increasing prevalence of cardiovascular diseases and a growing aging population are driving market growth. Opportunities in the market lie in emerging economies where there is a rising demand for minimally invasive procedures, as well as the potential for partnerships and collaborations between key players to develop novel drug-eluting stent technologies. Regulatory approvals for new products and expansions into untapped regions present further avenues for growth in the Global Drug-eluting Stents Market.
The Global Drug-eluting Stents Market faces several challenges, including intense competition among key players leading to pricing pressures and profit margins constraints. Additionally, stringent regulations and approval processes for new stent technologies can hinder market growth and innovation. The market is also susceptible to shifts in healthcare policies and reimbursement dynamics, impacting the adoption rates of drug-eluting stents. Rising concerns over the long-term safety and efficacy of these devices, as well as the potential for adverse events such as stent thrombosis, further contribute to challenges in market expansion. Overall, navigating these obstacles requires companies to invest significantly in research and development to address regulatory requirements, product safety concerns, and market competitiveness.
The Global Drug-eluting Stents Market is primarily driven by the increasing prevalence of cardiovascular diseases, especially coronary artery disease, coupled with a growing aging population globally. The rising adoption of minimally invasive procedures for the treatment of coronary artery disease is also fueling market growth, as drug-eluting stents offer a less invasive alternative to traditional open-heart surgeries. Technological advancements in stent design and materials, leading to improved efficacy and safety profiles, are further propelling market expansion. Additionally, the increasing focus on research and development activities by key market players to enhance product offerings and develop innovative stent technologies is driving the market forward. The growing demand for drug-eluting stents in emerging economies due to improving healthcare infrastructure and rising healthcare expenditure is also contributing to market growth.
Government policies related to the Global Drug-eluting Stents Market primarily focus on regulatory approval processes, reimbursement policies, and market access. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in Europe have stringent requirements for the approval of drug-eluting stents to ensure their safety and efficacy. Reimbursement policies vary across countries, with some governments providing coverage for these devices under certain conditions. Additionally, market access is influenced by government procurement policies and pricing regulations, which can impact the availability and affordability of drug-eluting stents for patients. Overall, government policies play a crucial role in shaping the landscape of the Global Drug-eluting Stents Market by ensuring compliance with quality standards, facilitating access to innovative technologies, and promoting equitable healthcare delivery.
The Global Drug-eluting Stents Market is expected to witness steady growth in the coming years, driven by the rising prevalence of cardiovascular diseases, advancements in stent technology, and increasing adoption of minimally invasive procedures. The growing aging population and lifestyle factors contributing to heart-related issues will further fuel the demand for drug-eluting stents. Additionally, ongoing research and development activities aimed at improving the efficacy and safety of these stents are likely to drive market expansion. However, challenges such as stringent regulatory requirements and the emergence of alternative treatment options may hinder market growth to some extent. Overall, the Global Drug-eluting Stents Market is projected to experience moderate growth, with key players focusing on innovation and strategic collaborations to maintain a competitive edge in the market.
In the Global Drug-eluting Stents Market, regional insights show varying trends across different regions. Asia is expected to witness significant growth due to increasing prevalence of cardiovascular diseases and improving healthcare infrastructure. North America holds a dominant position in the market owing to the high adoption rate of advanced medical technologies and favorable reimbursement policies. Europe is also a key market with a strong focus on research and development activities in the healthcare sector. The Middle East and Africa region is experiencing steady growth, supported by rising awareness about cardiovascular diseases and increasing healthcare investments. Latin America is projected to show promising growth opportunities due to expanding healthcare facilities and growing demand for minimally invasive procedures.
Global Drug-eluting Stents Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Drug-eluting Stents Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Drug-eluting Stents Market Revenues & Volume, 2021 & 2031F |
3.3 Global Drug-eluting Stents Market - Industry Life Cycle |
3.4 Global Drug-eluting Stents Market - Porter's Five Forces |
3.5 Global Drug-eluting Stents Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Drug-eluting Stents Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Drug-eluting Stents Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.8 Global Drug-eluting Stents Market Revenues & Volume Share, By Generation, 2021 & 2031F |
3.9 Global Drug-eluting Stents Market Revenues & Volume Share, By Scaffold, 2021 & 2031F |
3.10 Global Drug-eluting Stents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Global Drug-eluting Stents Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Drug-eluting Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Drug-eluting Stents Market Trends |
6 Global Drug-eluting Stents Market, 2021 - 2031 |
6.1 Global Drug-eluting Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Drug-eluting Stents Market, Revenues & Volume, By Polymer-based, 2021 - 2031 |
6.1.3 Global Drug-eluting Stents Market, Revenues & Volume, By Polymer-free, 2021 - 2031 |
6.2 Global Drug-eluting Stents Market, Revenues & Volume, By Drug, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Drug-eluting Stents Market, Revenues & Volume, By Sirolimus, 2021 - 2031 |
6.2.3 Global Drug-eluting Stents Market, Revenues & Volume, By Paclitaxel, 2021 - 2031 |
6.2.4 Global Drug-eluting Stents Market, Revenues & Volume, By Zotarolimus, 2021 - 2031 |
6.2.5 Global Drug-eluting Stents Market, Revenues & Volume, By Everolimus, 2021 - 2031 |
6.2.6 Global Drug-eluting Stents Market, Revenues & Volume, By Biolimus, 2021 - 2031 |
6.2.7 Global Drug-eluting Stents Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Drug-eluting Stents Market, Revenues & Volume, By Generation, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Drug-eluting Stents Market, Revenues & Volume, By 1st Generation, 2021 - 2031 |
6.3.3 Global Drug-eluting Stents Market, Revenues & Volume, By 2nd Generation, 2021 - 2031 |
6.3.4 Global Drug-eluting Stents Market, Revenues & Volume, By 3rd Generation, 2021 - 2031 |
6.3.5 Global Drug-eluting Stents Market, Revenues & Volume, By 4th Generation, 2021 - 2031 |
6.4 Global Drug-eluting Stents Market, Revenues & Volume, By Scaffold, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Drug-eluting Stents Market, Revenues & Volume, By Cobalt-Chromium, 2021 - 2031 |
6.4.3 Global Drug-eluting Stents Market, Revenues & Volume, By Platinum-Chromium, 2021 - 2031 |
6.4.4 Global Drug-eluting Stents Market, Revenues & Volume, By Nitinol, 2021 - 2031 |
6.4.5 Global Drug-eluting Stents Market, Revenues & Volume, By Biodegradable, 2021 - 2031 |
6.4.6 Global Drug-eluting Stents Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Drug-eluting Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Drug-eluting Stents Market, Revenues & Volume, By Coronary Diseases, 2021 - 2031 |
6.5.3 Global Drug-eluting Stents Market, Revenues & Volume, By Peripheral Vascular Diseases, 2021 - 2031 |
6.6 Global Drug-eluting Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Drug-eluting Stents Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.6.3 Global Drug-eluting Stents Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
7 North America Drug-eluting Stents Market, Overview & Analysis |
7.1 North America Drug-eluting Stents Market Revenues & Volume, 2021 - 2031 |
7.2 North America Drug-eluting Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Drug-eluting Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Drug-eluting Stents Market, Revenues & Volume, By Drug, 2021 - 2031 |
7.5 North America Drug-eluting Stents Market, Revenues & Volume, By Generation, 2021 - 2031 |
7.6 North America Drug-eluting Stents Market, Revenues & Volume, By Scaffold, 2021 - 2031 |
7.7 North America Drug-eluting Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
7.8 North America Drug-eluting Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Drug-eluting Stents Market, Overview & Analysis |
8.1 Latin America (LATAM) Drug-eluting Stents Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Drug-eluting Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Drug-eluting Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Drug-eluting Stents Market, Revenues & Volume, By Drug, 2021 - 2031 |
8.5 Latin America (LATAM) Drug-eluting Stents Market, Revenues & Volume, By Generation, 2021 - 2031 |
8.6 Latin America (LATAM) Drug-eluting Stents Market, Revenues & Volume, By Scaffold, 2021 - 2031 |
8.7 Latin America (LATAM) Drug-eluting Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
8.8 Latin America (LATAM) Drug-eluting Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Drug-eluting Stents Market, Overview & Analysis |
9.1 Asia Drug-eluting Stents Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Drug-eluting Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Drug-eluting Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Drug-eluting Stents Market, Revenues & Volume, By Drug, 2021 - 2031 |
9.5 Asia Drug-eluting Stents Market, Revenues & Volume, By Generation, 2021 - 2031 |
9.6 Asia Drug-eluting Stents Market, Revenues & Volume, By Scaffold, 2021 - 2031 |
9.7 Asia Drug-eluting Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
9.8 Asia Drug-eluting Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Drug-eluting Stents Market, Overview & Analysis |
10.1 Africa Drug-eluting Stents Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Drug-eluting Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Drug-eluting Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Drug-eluting Stents Market, Revenues & Volume, By Drug, 2021 - 2031 |
10.5 Africa Drug-eluting Stents Market, Revenues & Volume, By Generation, 2021 - 2031 |
10.6 Africa Drug-eluting Stents Market, Revenues & Volume, By Scaffold, 2021 - 2031 |
10.7 Africa Drug-eluting Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
10.8 Africa Drug-eluting Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Drug-eluting Stents Market, Overview & Analysis |
11.1 Europe Drug-eluting Stents Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Drug-eluting Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Drug-eluting Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Drug-eluting Stents Market, Revenues & Volume, By Drug, 2021 - 2031 |
11.5 Europe Drug-eluting Stents Market, Revenues & Volume, By Generation, 2021 - 2031 |
11.6 Europe Drug-eluting Stents Market, Revenues & Volume, By Scaffold, 2021 - 2031 |
11.7 Europe Drug-eluting Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
11.8 Europe Drug-eluting Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Drug-eluting Stents Market, Overview & Analysis |
12.1 Middle East Drug-eluting Stents Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Drug-eluting Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Drug-eluting Stents Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Drug-eluting Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Drug-eluting Stents Market, Revenues & Volume, By Drug, 2021 - 2031 |
12.5 Middle East Drug-eluting Stents Market, Revenues & Volume, By Generation, 2021 - 2031 |
12.6 Middle East Drug-eluting Stents Market, Revenues & Volume, By Scaffold, 2021 - 2031 |
12.7 Middle East Drug-eluting Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
12.8 Middle East Drug-eluting Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Drug-eluting Stents Market Key Performance Indicators |
14 Global Drug-eluting Stents Market - Export/Import By Countries Assessment |
15 Global Drug-eluting Stents Market - Opportunity Assessment |
15.1 Global Drug-eluting Stents Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Drug-eluting Stents Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Drug-eluting Stents Market Opportunity Assessment, By Drug, 2021 & 2031F |
15.4 Global Drug-eluting Stents Market Opportunity Assessment, By Generation, 2021 & 2031F |
15.5 Global Drug-eluting Stents Market Opportunity Assessment, By Scaffold, 2021 & 2031F |
15.6 Global Drug-eluting Stents Market Opportunity Assessment, By Application, 2021 & 2031F |
15.7 Global Drug-eluting Stents Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Drug-eluting Stents Market - Competitive Landscape |
16.1 Global Drug-eluting Stents Market Revenue Share, By Companies, 2024 |
16.2 Global Drug-eluting Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |